Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionals (13 November 2021)

Summary

Uptake of open-source automated insulin delivery systems is increasing globally and there is growing real-world, user-driven evidence around the safety and effectiveness of these systems. This article in The Lancet Diabetes & Endocrinology seeks to provide, from an international perspective:

• a review of the current evidence
• a description of the technologies
• discussion of the ethical and legal considerations
• a healthcare consensus supporting the implementation of open-source systems in clinical settings, with detailed clinical guidance.

The authors make recommendations for key stakeholders involved in diabetes technologies, including developers, regulators, and industry.